Zhongjie Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhongjie Liu has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Jian Liu
Department of Anesthesia, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China
4 shared publicationsQinming Liao
Department of Neurosurgery, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China
4 shared publications- Xusheng Wang
School of Pharmaceutical Sciences (Shenzhen), Shenzhen Campus of Sun Yat-Sen University, Sun Yat-Sen University, Shenzhen, China
4 shared publications Jun Chen
Department of Neurosurgery, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan, China
3 shared publicationsKeke Fan
3 shared publicationsFuye Li
Department of Critical Care Medicine, Nanfang Hospital Southern Medical University Guangzhou China
2 shared publications
Latest Publications
- Open Access
- 15 August 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
PARP1 contributes to neuropathic pain via GPX4-dependent sensory neuron ferroptosis in nerve-injured mice
Neuropathic pain is associated with sensory neuron injury, and ferroptosis has been implicated in neuronal damage and death. However, the regulatory mechanism of ferroptosis in neuropathic pain remains unclear. This study aimed to investigate poly-(ADP-ribose) polymerase 1 (PARP1) in regulating sensory neuron ferroptosis and to assess its potential therapeutic role in neuropathic pain. A chronic constriction nerve injury (CCI) mouse model was established to examine how ferroptosis in sensory neurons contributes to CCI-induced neuropathic pain. We analyzed the expression of ferroptosis-related key gene (GPX4, FPN1, FSP1, TFR1, DMT1) and ferroptosis in dorsal root ganglion (DRG) neurons, along with PARP1 activity. Blocking PARP1 activity with PJ34 or olaparib, or conditionally knocking out neuronal PARP1, was performed to assess effects on GPX4 expression, ferroptosis, and neuropathic pain behavior. Nerve injury downregulated GPX4 expression and enhanced ferroptosis in DRG neurons, accompanied by increased PARP1 activity. Using sensory neuron-specific PARP1 conditional knockout mice, we demonstrated that neuronal PARP1 deletion upregulated GPX4 expression, reduced ferroptosis, and alleviated neuropathic pain-like behaviors. Blocking GPX4 activity induced pain sensitization in normal mice. Inhibition of ferroptosis or administration of PARP1 inhibitors significantly alleviated pain-like behaviors in CCI mice. Following nerve injury, PARP1 overactivation drives neuropathic pain by suppressing GPX4 and promoting ferroptosis in DRG neurons. Conditional knockout or pharmacological inhibition of PARP1 reversed these effects and alleviated pain. Thus, the PARP1-GPX4 axis represents a promising therapeutic target.
- 15 August 2026
- Published by Springer Nature in Cell Death Discovery
- Vol. 12 (1)
Open AccessPARP1 contributes to neuropathic pain via GPX4-dependent sensory neuron ferroptosis in nerve-injured mice
Neuropathic pain is associated with sensory neuron injury, and ferroptosis has been implicated in neuronal damage and death. However, the regulatory mechanism of ferroptosis in neuropathic pain remains unclear. This study aimed to investigate poly-(ADP-ribose) polymerase 1 (PARP1) in regulating sensory neuron ferroptosis and to assess its potential therapeutic role in neuropathic pain. A chronic constriction nerve injury (CCI) mouse model was established to examine how ferroptosis in sensory neurons contributes to CCI-induced neuropathic pain. We analyzed the expression of ferroptosis-related key gene (GPX4, FPN1, FSP1, TFR1, DMT1) and ferroptosis in dorsal root ganglion (DRG) neurons, along with PARP1 activity. Blocking PARP1 activity with PJ34 or olaparib, or conditionally knocking out neuronal PARP1, was performed to assess effects on GPX4 expression, ferroptosis, and neuropathic pain behavior. Nerve injury downregulated GPX4 expression and enhanced ferroptosis in DRG neurons, accompanied by increased PARP1 activity. Using sensory neuron-specific PARP1 conditional knockout mice, we demonstrated that neuronal PARP1 deletion upregulated GPX4 expression, reduced ferroptosis, and alleviated neuropathic pain-like behaviors. Blocking GPX4 activity induced pain sensitization in normal mice. Inhibition of ferroptosis or administration of PARP1 inhibitors significantly alleviated pain-like behaviors in CCI mice. Following nerve injury, PARP1 overactivation drives neuropathic pain by suppressing GPX4 and promoting ferroptosis in DRG neurons. Conditional knockout or pharmacological inhibition of PARP1 reversed these effects and alleviated pain. Thus, the PARP1-GPX4 axis represents a promising therapeutic target.
- 10 August 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 833
Defective ferritinophagy was involved in high glucose-induced neuron oxidative damage in ND7/23 cells
- 10 August 2026
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 833
Defective ferritinophagy was involved in high glucose-induced neuron oxidative damage in ND7/23 cells
- Open Access
- 16 July 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Perioperative anesthetic management and procedural sedation in a child with type 1 congenital long QT Syndrome undergoing serial procedures: a case report
Congenital long QT syndromes (cLQTS) are inherited cardiac channelopathies that predispose pediatric patients to ventricular arrhythmias, particularly Torsades de Pointes (TdP), during the perioperative period. Data regarding repeated anesthetic and sedation exposures in this high-risk population remain limited. We present an 8-year-old boy with genetically confirmed LQT1 and multiple systemic comorbidities who underwent five general anesthetics and four procedural sedations within a four-month timeframe. Management focused on preserving hemodynamic stability, attenuating autonomic fluctuations, minimizing drug-induced prolongation of cardiac repolarization, and ensuring immediate availability of rescue resources. Anesthesia was maintained via balanced volatile or intravenous regimens, while procedural sedation employed dexmedetomidine-midazolam based anxiolysis. Across all nine interventions, no TdP, malignant ventricular tachyarrhythmia, treatment-requiring bradycardia, or cardiac arrest was documented. This single-patient experience describes repeated general anesthesia and procedural sedation in a child with LQT1 without documented adverse cardiac events.
- 16 July 2026
- Published by Springer Nature in BMC Anesthesiology
- Vol. 26 (1)
Open AccessPerioperative anesthetic management and procedural sedation in a child with type 1 congenital long QT Syndrome undergoing serial procedures: a case report
Congenital long QT syndromes (cLQTS) are inherited cardiac channelopathies that predispose pediatric patients to ventricular arrhythmias, particularly Torsades de Pointes (TdP), during the perioperative period. Data regarding repeated anesthetic and sedation exposures in this high-risk population remain limited. We present an 8-year-old boy with genetically confirmed LQT1 and multiple systemic comorbidities who underwent five general anesthetics and four procedural sedations within a four-month timeframe. Management focused on preserving hemodynamic stability, attenuating autonomic fluctuations, minimizing drug-induced prolongation of cardiac repolarization, and ensuring immediate availability of rescue resources. Anesthesia was maintained via balanced volatile or intravenous regimens, while procedural sedation employed dexmedetomidine-midazolam based anxiolysis. Across all nine interventions, no TdP, malignant ventricular tachyarrhythmia, treatment-requiring bradycardia, or cardiac arrest was documented. This single-patient experience describes repeated general anesthesia and procedural sedation in a child with LQT1 without documented adverse cardiac events.
- Open Access
- 13 May 2026
- Published by Springer Nature in Cell Discovery
- Vol. 12 (1)
A negative survival pressure selection system enables GPCR antagonist screening
- 13 May 2026
- Published by Springer Nature in Cell Discovery
- Vol. 12 (1)
Open AccessA negative survival pressure selection system enables GPCR antagonist screening
- Open Access
- 19 May 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70440
ALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain
Background: Diabetic peripheral neuropathic pain (DPNP) is one of the most common complications in diabetic patients. Current treatment strategies primarily focus on blood glucose control and pain relief, but they often yield limited effects. Ferroptosis, a regulated form of cell death driven by lipid peroxidation and iron imbalance, plays a crucial role in various diseases, including neuropathic pain.Methods: In this study, we employed a combined bioinformatics and machine learning approach to identify genes most strongly associated with DPNP and ferroptosis. Subsequently, we established a DPNP mouse model via streptozotocin (STZ) injection and a high‐glucose‐induced SH‐SY5Y cell injury model. ALOX15 was knocked down in the in vitro model using siRNA transfection.Results: Bioinformatics analysis identified ALOX15 as a hub gene linking DPNP and ferroptosis. In both in vivo and in vitro DPNP models, ALOX15 expression was significantly upregulated and correlated with ferroptosis biomarkers. Knockdown of ALOX15 in the cellular model mitigated high‐glucose‐induced ferroptosis, reduced lipid peroxidation and free iron ion accumulation, and restored cell viability.Conclusion: In conclusion, ALOX15 contributes to the onset and progression of DPNP by promoting ferroptosis, and its knockdown effectively suppresses ferroptosis, providing a novel target and strategy for DPNP treatment.
- 19 May 2025
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70440
Open AccessALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain
Background: Diabetic peripheral neuropathic pain (DPNP) is one of the most common complications in diabetic patients. Current treatment strategies primarily focus on blood glucose control and pain relief, but they often yield limited effects. Ferroptosis, a regulated form of cell death driven by lipid peroxidation and iron imbalance, plays a crucial role in various diseases, including neuropathic pain.Methods: In this study, we employed a combined bioinformatics and machine learning approach to identify genes most strongly associated with DPNP and ferroptosis. Subsequently, we established a DPNP mouse model via streptozotocin (STZ) injection and a high‐glucose‐induced SH‐SY5Y cell injury model. ALOX15 was knocked down in the in vitro model using siRNA transfection.Results: Bioinformatics analysis identified ALOX15 as a hub gene linking DPNP and ferroptosis. In both in vivo and in vitro DPNP models, ALOX15 expression was significantly upregulated and correlated with ferroptosis biomarkers. Knockdown of ALOX15 in the cellular model mitigated high‐glucose‐induced ferroptosis, reduced lipid peroxidation and free iron ion accumulation, and restored cell viability.Conclusion: In conclusion, ALOX15 contributes to the onset and progression of DPNP by promoting ferroptosis, and its knockdown effectively suppresses ferroptosis, providing a novel target and strategy for DPNP treatment.
- 25 March 2025
- Published by Elsevier in Neuroscience
- Vol. 573, 286-299
Defective PINK1-dependent mitophagy is involved in high glucose-induced neurotoxicity
- 25 March 2025
- Published by Elsevier in Neuroscience
- Vol. 573, 286-299
Defective PINK1-dependent mitophagy is involved in high glucose-induced neurotoxicity
- 10 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (5) , e70460
Intensive stress impedes hair follicle growth through triggering cell cycle arrest of hair follicle stem cells
The detrimental effects of stress on hair growth are supported by empirical and experimental evidence, but the specific impact and mechanisms remain poorly understood. Here we utilized two intensive stress paradigms, repeated resiniferatoxin (RTX) injections and physical restraint in mice, to assess the effects of intensive stress on hair follicle growth after depilation. Initially, macroscopic pictures of the mice dorsal skin and HE staining showed a substantial inhibition of depilation‐induced hair growth in both telogen and anagen hair follicle growth under intensive stress induced by RTX and restraint. Mechanistically, single‐cell RNA sequencing analysis of mice skin under intensive stress highlighted a significant downregulation of cell‐cycle genes and upregulation of the cAMP signaling pathway in Lgr5 + hair follicle stem cells (HFSCs). Notably, the sympathetic nervous system was activated under intensive stress. Then, the neurotransmitter noradrenaline (NA), a secretion of the sympathetic nervous system, and 8‐bromo‐cAMP, a cAMP analog, were used to manifest the inhibitory effect of the sympathetic nervous system on HaCaT cell proliferation, as evidenced by the results of decreased cell activity and colony formation, downregulated expression of cyclin D1/2 and CDK4, the increased percentage of G0/G1, and decreased percentage of the S phase. Importantly, hair follicle regeneration was significantly inhibited by NA and 8‐bromo‐cAMP in mice. Collectively, our study suggests that intensive stress inhibits the cell cycle of hair follicle growth through the sympathetic nervous system/NA/cAMP pathway, thus providing a mechanistic insight into intensive stress‐induced inhibition in hair follicle growth.
- 10 March 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (5) , e70460
Intensive stress impedes hair follicle growth through triggering cell cycle arrest of hair follicle stem cells
The detrimental effects of stress on hair growth are supported by empirical and experimental evidence, but the specific impact and mechanisms remain poorly understood. Here we utilized two intensive stress paradigms, repeated resiniferatoxin (RTX) injections and physical restraint in mice, to assess the effects of intensive stress on hair follicle growth after depilation. Initially, macroscopic pictures of the mice dorsal skin and HE staining showed a substantial inhibition of depilation‐induced hair growth in both telogen and anagen hair follicle growth under intensive stress induced by RTX and restraint. Mechanistically, single‐cell RNA sequencing analysis of mice skin under intensive stress highlighted a significant downregulation of cell‐cycle genes and upregulation of the cAMP signaling pathway in Lgr5 + hair follicle stem cells (HFSCs). Notably, the sympathetic nervous system was activated under intensive stress. Then, the neurotransmitter noradrenaline (NA), a secretion of the sympathetic nervous system, and 8‐bromo‐cAMP, a cAMP analog, were used to manifest the inhibitory effect of the sympathetic nervous system on HaCaT cell proliferation, as evidenced by the results of decreased cell activity and colony formation, downregulated expression of cyclin D1/2 and CDK4, the increased percentage of G0/G1, and decreased percentage of the S phase. Importantly, hair follicle regeneration was significantly inhibited by NA and 8‐bromo‐cAMP in mice. Collectively, our study suggests that intensive stress inhibits the cell cycle of hair follicle growth through the sympathetic nervous system/NA/cAMP pathway, thus providing a mechanistic insight into intensive stress‐induced inhibition in hair follicle growth.
- Open Access
- 21 February 2025
- Published by Springer Nature in Research Square
ALOX15-Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain
Diabetic peripheral neuropathic pain (DPNP) is a prevalent complication among diabetic patients. Recent studies have confirmed that ferroptosis, an iron-dependent cell death driven by lipid peroxidation, plays a key role in DPNP development. However, biomarkers related to ferroptosis in DPNP remain undiscovered. Core genes related to DPNP were identified using bioinformatics. By assessing the mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL), a mouse model of DPNP was established, along with a high-glucose-stimulated SH-SY5Y cell model. The combination of these two models allows for an in-depth investigation of the molecular biological mechanisms underlying DPNP. The viability and ferroptosis of these cells underwent evaluation via flow cytometry, CCK8 assays, Fe²⁺ assays, along with Western blotting. Differential expression analysis and random forest results identified Arachidonate 15-Lipoxygenase (ALOX15) as a core gene associated with DPNP-related ferroptosis. Subsequently, we verified elevated levels of iron death and ALOX15 expression in neurons using both in vivo and in vitro models. Notably, silencing ALOX15 markedly inhibited high glucose-induced ferroptosis within SH-SY5Y cells and restored neuronal viability. Our findings indicate that ALOX15 promotes the development of DPNP by mediating neuronal ferroptosis, providing new insights into the role of ALOX15 as a biomarker for DPNP while proposing innovative strategies to prevent and treat DPNP.
- 21 February 2025
- Published by Springer Nature in Research Square
Open AccessALOX15-Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain
Diabetic peripheral neuropathic pain (DPNP) is a prevalent complication among diabetic patients. Recent studies have confirmed that ferroptosis, an iron-dependent cell death driven by lipid peroxidation, plays a key role in DPNP development. However, biomarkers related to ferroptosis in DPNP remain undiscovered. Core genes related to DPNP were identified using bioinformatics. By assessing the mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL), a mouse model of DPNP was established, along with a high-glucose-stimulated SH-SY5Y cell model. The combination of these two models allows for an in-depth investigation of the molecular biological mechanisms underlying DPNP. The viability and ferroptosis of these cells underwent evaluation via flow cytometry, CCK8 assays, Fe²⁺ assays, along with Western blotting. Differential expression analysis and random forest results identified Arachidonate 15-Lipoxygenase (ALOX15) as a core gene associated with DPNP-related ferroptosis. Subsequently, we verified elevated levels of iron death and ALOX15 expression in neurons using both in vivo and in vitro models. Notably, silencing ALOX15 markedly inhibited high glucose-induced ferroptosis within SH-SY5Y cells and restored neuronal viability. Our findings indicate that ALOX15 promotes the development of DPNP by mediating neuronal ferroptosis, providing new insights into the role of ALOX15 as a biomarker for DPNP while proposing innovative strategies to prevent and treat DPNP.
- Open Access
- 12 January 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-11
BMP4 regulates differentiation of nestin-positive stem cells into melanocytes
Hair follicle (HF) development and pigmentation are complex processes governed by various signaling pathways, such as TGF-β and FGF signaling pathways. Nestin + (neural crest like) stem cells are also expressed in HF stem cells, particularly in the bulge and dermal papilla region. However, the specific role and differentiation potential of these Nestin-positive cells within the HF remain unclear, especially regarding their contribution to melanocyte formation and hair pigmentation. Bone morphogenetic protein 4 (BMP4), members of the TGFβ family, has been implicated in regulating HF growth, coloration, and related cellular behaviors. Its role in directing Nestin-positive cells toward a melanocytic lineage has yet to be fully explored. In this study, mouse HF organoids were constructed and shown to be an ideal model for studying HF growth and development in vitro. Using this model as a basis, we demonstrated that BMP4 controls HF coloration as well as its length, number, and even size. Furthermore, Nestin-positive cells in the HF-especially those in the bulge region-differentiate into melanocytes, which produce the pigments that give HF its color under BMP4 stimulation. The resulting increase in pigmentation within the mouse HF organoids underscores that BMP4 has a major regulatory role in the formation of melanocytes from Nestin-positive stem cells. This research provides insights into the cellular mechanisms underlying hair pigmentation and suggests potential therapeutic applications for pigmentation disorders.
- 12 January 2025
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 82 (1) , 1-11
Open AccessBMP4 regulates differentiation of nestin-positive stem cells into melanocytes
Hair follicle (HF) development and pigmentation are complex processes governed by various signaling pathways, such as TGF-β and FGF signaling pathways. Nestin + (neural crest like) stem cells are also expressed in HF stem cells, particularly in the bulge and dermal papilla region. However, the specific role and differentiation potential of these Nestin-positive cells within the HF remain unclear, especially regarding their contribution to melanocyte formation and hair pigmentation. Bone morphogenetic protein 4 (BMP4), members of the TGFβ family, has been implicated in regulating HF growth, coloration, and related cellular behaviors. Its role in directing Nestin-positive cells toward a melanocytic lineage has yet to be fully explored. In this study, mouse HF organoids were constructed and shown to be an ideal model for studying HF growth and development in vitro. Using this model as a basis, we demonstrated that BMP4 controls HF coloration as well as its length, number, and even size. Furthermore, Nestin-positive cells in the HF-especially those in the bulge region-differentiate into melanocytes, which produce the pigments that give HF its color under BMP4 stimulation. The resulting increase in pigmentation within the mouse HF organoids underscores that BMP4 has a major regulatory role in the formation of melanocytes from Nestin-positive stem cells. This research provides insights into the cellular mechanisms underlying hair pigmentation and suggests potential therapeutic applications for pigmentation disorders.
- 9 January 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 233, 116744
Direct reprogramming of human fibroblasts into hair-inducing dermal papilla cell-like cells by a single small molecule
- 9 January 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 233, 116744
Direct reprogramming of human fibroblasts into hair-inducing dermal papilla cell-like cells by a single small molecule